106 related articles for article (PubMed ID: 4567560)
1. Phenformin and vascular complications of diabetes.
Med Lett Drugs Ther; 1972 Jan; 14(1):1-2. PubMed ID: 4567560
[No Abstract] [Full Text] [Related]
2. The University Group Diabetes Program. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. V. Evaluation of pheniformin therapy.
Diabetes; 1975; 24 Suppl 1():65-184. PubMed ID: 1090475
[No Abstract] [Full Text] [Related]
3. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VIII. Evaluation of insulin therapy: final report.
Diabetes; 1982 Nov; 31 Suppl 5():1-81. PubMed ID: 6757026
[No Abstract] [Full Text] [Related]
4. The UGDP--tolbutamide and mortality.
Knowles HC
Horm Metab Res; 1974; Suppl 4():186-8. PubMed ID: 4609432
[No Abstract] [Full Text] [Related]
5. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin results.
Knatterud GL; Meinert CL; Klimt CR; Osborne RK; Martin DB
JAMA; 1971 Aug; 217(6):777-84. PubMed ID: 4935344
[No Abstract] [Full Text] [Related]
6. The UGDP study.
Salsburg DS
JAMA; 1971 Dec; 218(11):1704-5. PubMed ID: 4940315
[No Abstract] [Full Text] [Related]
7. A progress report on the University Group Diabetes Program.
Prout TE
Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):244-51. PubMed ID: 809369
[TBL] [Abstract][Full Text] [Related]
8. The controversial American University Group Diabetes Study--a look at sulfonylurea and biguanide therapy.
Kilo C; Williamson JR
Horm Metab Res Suppl; 1985; 15():102-4. PubMed ID: 3908276
[No Abstract] [Full Text] [Related]
9. Editorial: Oral hypoglycemic drugs.
Scoville AB
J Tenn Med Assoc; 1975 Apr; 68(4):319-20. PubMed ID: 1117723
[No Abstract] [Full Text] [Related]
10. [Oral therapy in diabetes].
Kirkeby K
Tidsskr Nor Laegeforen; 1973 Aug; 93(23):1620-1. PubMed ID: 4588817
[No Abstract] [Full Text] [Related]
11. [The venture of University Group Diabetes Program (UGDP). Some personal reflexions. Tolbutamide and phenformin under accusation].
Pirart J
Nouv Presse Med; 1972 Jan; 1(5):325-8. PubMed ID: 5010448
[No Abstract] [Full Text] [Related]
12. The influence of diagnostic criteria on the mortality findings in the University Group Diabetic Programme study of diabetic therapy.
Gray RH
Med J Aust; 1973 Mar; 1(12):594-6. PubMed ID: 4573383
[No Abstract] [Full Text] [Related]
13. Antidiabetic agents and vascular events.
Keen H
J Clin Pathol Suppl (R Coll Pathol); 1975; 9():99-105. PubMed ID: 783218
[No Abstract] [Full Text] [Related]
14. Comments on the UGDP study.
Schöffling K
Horm Metab Res; 1974; Suppl 4():188-91. PubMed ID: 4608018
[No Abstract] [Full Text] [Related]
15. [Should the prescription of oral antidiabetic drugs be more limited? Results from controlled clinical trials].
Folling I
Tidsskr Nor Laegeforen; 1973 Aug; 93(23):1604-6. PubMed ID: 4769481
[No Abstract] [Full Text] [Related]
16. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results.
Meinert CL; Knatterud GL; Prout TE; Klimt CR
Diabetes; 1970; 19():Suppl:789-830. PubMed ID: 4926376
[No Abstract] [Full Text] [Related]
17. Letter: Oral hypoglycaemics in diabetes mellitus.
Keen H; Jarrett RJ; Fuller JH
Lancet; 1975 Nov; 2(7940):865. PubMed ID: 53342
[No Abstract] [Full Text] [Related]
18. [Experience with phenformin in combination with insulin or oral antidiabetic drugs in ambulatory diabetic patients].
Stratmann FW
Med Welt; 1976 Feb; 27(6):273-6. PubMed ID: 768703
[No Abstract] [Full Text] [Related]
19. [Causes of death in diabetes mellitus].
Akhmetzianov AM; Mazovetskiĭ AG; Kliachko VR
Probl Endokrinol (Mosk); 1975; 21(1):103-11. PubMed ID: 1094446
[No Abstract] [Full Text] [Related]
20. [Heart death and oral antidiabetics; the last judgement].
Touber JL
Ned Tijdschr Geneeskd; 1975 Sep; 119(39):1506-8. PubMed ID: 1101083
[No Abstract] [Full Text] [Related]
[Next] [New Search]
